Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.04 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |